FES and FDG PET in ILC and IDC: Where Is the Clinical Impact?
Are you using FES PET/CT for determining which patients will not respond to endocrine therapy?

This activity may be available in multiple formats or from different sponsors. A self-learning activity can be completed only once per biennium.

Target Audience and Goal Statement
This activity is intended for radiologists, radiologic technologists, hematologists/oncologists, and pathologists.

The goal of this activity is for the learner to be better able to assess patients who may be at increased risk for breast cancer.

LEARNING OBJECTIVES 

Upon completion of this activity, participants will: 

Have increased knowledge regarding the

• Efficacy of positron emission tomography (PET) images for treatment planning
• Clinical data evaluating estrogen receptor (ER)-targeting and PET tracers in invasive lobular carcinoma (ILC)

Demonstrate greater confidence in their ability to

• Effectively guide breast cancer treatment through the use of current and emerging imaging technologies

ACCREDITATION AND CREDIT
This activity has been approved by the American Society of Radiologic Technologists (ASRT) for 0.75 hours of ARRT Category A continuing education credit.

• Log-in to your account at www.icpme.us
• Enroll in and view the entire educational activity session.
• At the conclusion of the lecture, close the Vimeo window.
• Access the POSTTEST and EVALUATION by clicking on the appropriate icons located on the left sidebar.
• A passing grade of at least 75% is required to receive credit. You may take the test up to 3 times.
• Upon receipt of a passing grade, you will be able to print a certificate of credit from your account at www.icpme.us
• A summary of credits earned is available by clicking on the TRANSCRIPT REPORT tab located in your account.

FACULTY
Gary A. Ulaner, MD, PhD, FACNM
Director of Molecular Imaging and Therapy
Hoag Family Cancer Institute
Professor of Radiology and Translational Genomics
University of Southern California
Newport Beach, California

Questions?
For questions regarding this program, please contact ICPME: Email: information@icpmed.com

PROVIDED BY